v3.26.1
Condensed Balance Sheet - USD ($)
Apr. 30, 2026
Oct. 31, 2025
Current Assets    
Cash and cash equivalents $ 151,000
Prepaid expense 140,000
Amount due from sponsor 233,381
Deferred offering costs 40,000
Total Current Assets 524,381 40,000
Cash held in Trust Account 112,907,509
Total Assets 113,431,890 40,000
Current Liabilities    
Accrued liabilities and other payables 13,494
Total Current Liabilities 13,994 64,487
Total Liabilities 13,994 64,487
Commitments and Contingencies  
Ordinary shares subject to possible redemption, $0.0001 par value; 11,200,000 shares subject to possible redemption as of April 30, 2026 112,907,509
Shareholders’ Equity (Deficit)    
Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,362,069 and 4,694,069 shares issued and outstanding as of October 31, 2025 and April 30, 2026, respectively [1] 469 436
Additional paid-in capital 290,469 24,564
Share subscription receivable (25,000)
Retained earnings/ (accumulated deficit) 219,449 (24,487)
Total Shareholders’ Equity (Deficit) 510,387 (24,487)
Total Liabilities and Shareholders’ Equity (Deficit) 113,431,890 40,000
Related Party [Member]    
Current Liabilities    
Promissory note - related party $ 500 $ 64,487
[1] On March 30, 2026, the underwriter partially exercised their over-allotment option, resulting in 455,173 founder shares no longer subject to forfeiture.